Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Operating Leases (2023 - 2025)

Metagenomi (MGX) has disclosed Operating Leases for 3 consecutive years, with $34.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Leases fell 13.82% to $34.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $34.6 million, a 13.82% decrease, with the full-year FY2025 number at $34.6 million, down 13.82% from a year prior.
  • Operating Leases was $34.6 million for Q4 2025 at Metagenomi, down from $36.1 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $44.8 million in Q4 2023 to a low of $34.6 million in Q4 2025.
  • A 3-year average of $40.0 million and a median of $40.2 million in 2024 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: fell 10.3% in 2024, then decreased 13.82% in 2025.
  • Metagenomi's Operating Leases stood at $44.8 million in 2023, then dropped by 10.3% to $40.2 million in 2024, then decreased by 13.82% to $34.6 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Operating Leases are $34.6 million (Q4 2025), $36.1 million (Q3 2025), and $37.5 million (Q2 2025).